C.R. Sincock

C.R. Sincock is a highly accomplished individual with a diverse academic background and extensive professional experience in the fields of business, biotechnology, and aviation.

He pursued his education at prestigious institutions, including Harvard Business School where he completed his Master of Business Administration (M.B.A.), Harvard University where he studied A.B. in Economics, and The Johns Hopkins University where he earned his Master of Science (M.S.) in Biotechnology.

With a wealth of experience, C.R. Sincock has held key positions in various organizations, notably serving as the Chief Executive Officer at Avflight Corporation. He has also been involved with organizations such as the National Air Transportation Association, Dvant Pharma, Kriya Therapeutics, and the University of Michigan Biomedical Venture Fund in different capacities.

In his professional journey, C.R. Sincock has demonstrated his leadership skills and business acumen through roles such as Executive Chairman & Co-Founder at Dvant Pharma, Investment Advisory Board Member at University of Michigan Biomedical Venture Fund, and Founder & Managing Partner at Transhuman Capital among others.

His expertise extends to the aviation industry, where he has held significant positions like Executive Vice President at Avfuel Corporation, Director of International Business Development, and Investment Analyst at various organizations.

C.R. Sincock's experience also includes roles in financial analysis and strategic planning, evident from his past positions as an Investment Analyst at QVT Financial LP and internships at Acuity Brands and Long Point Capital.

Overall, C.R. Sincock's professional background reflects a dedication to business growth, biotechnology innovation, and strategic investment, making him a valuable asset in various industries.